Silvia Ezquerro et al. showed that the circulating acylation/deacetylation ghrelin ratio and TNF-α in obese patients with NAFLD were upregulated, while the level of deacetylated ghrelin decreased. The gene discussed is GHRL; the disease is metabolic dysfunction-associated steatotic liver disease.